The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity

Mukhopadhyay, P.; Baggelaar, M.; Erdelyi, K.; Cao, Z.; Cinar, R.; Fezza, F.; ... ; Stelt, M. van der (2016)

Article / Letter to editor

• All authors: Mukhopadhyay, P.; Baggelaar, M.; Erdelyi, K.; Cao, Z.; Cinar, R.; Fezza, F.; Ignatowska-Jankowska, B.; Wilkerson, J.; Gils, N. van; Hansen, T.; Ruben, M.; Soethoudt, M.; Heitman, L.; Kunos, G.; Maccarrone, M.; Lichtman, A.; Pacher, P.; Stelt, M. van der
• Date: 2016-02-28
• Journal: British Journal of Pharmacology
• Volume: 173
• Issue: 3
• Pages: 446–458
• DOI: doi:10.1111/bph.13338